Valeant Could Hike Allergan Offer To $200-Plus Per Share
Valeant Pharmaceuticals International Inc. said Monday that it could raise its takeover offer for Allergan Inc. to $200 per share or more, and again urged the Botox maker to sidle up...To view the full article, register now.
Already a subscriber? Click here to view full article